The inflammatory profile and liver damage of a sucrose-rich diet in mice

Journal of Nutritional Biochemistry

Volumn 25, Issue 2, 2014, Pages 193-200

  Oliveira, Liliane Soares C ^a   Santos, Daiane A ^a   Barbosa da Silva, Sandra ^a   Mandarim de Lacerda, Carlos A ^a   Aguila, Marcia B ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Adipokines; Adipose tissue; High fat diet; High sucrose diet; Liver

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; INSULIN; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RESISTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUCROSE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE DIET; CARBOHYDRATE METABOLISM; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; EPIDIDYMIS FAT; FATTY LIVER; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTROPHY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; LIVER INJURY; LIVER STRUCTURE; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; WESTERN BLOTTING;

ADIPOKINES; ADIPOSE TISSUE; HIGH-FAT DIET; HIGH-SUCROSE DIET; LIVER;

ADIPOSITY; ANIMALS; BLOTTING, WESTERN; DIETARY CARBOHYDRATES; INFLAMMATION; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; SUCROSE;

EID: 84892502707     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.10.006     Document Type: Article

References (50)

1. Barbosa-da-Silva S., Fraulob-Aquino J.C., Lopes J.R., Mandarim-de-Lacerda C.A., Aguila M.B. Weight cycling enhances adipose tissue inflammatory responses in male mice. PLoS One 2012, 7:e39837.
2. Barbosa-da-Silva S., da Silva N.C., Aguila M.B., Mandarim-de-Lacerda C.A. Liver damage is not reversed during the lean period in diet-induced weight cycling in mice. Hepatol Res 2013, 10.1111/hepr.12138.
3. Parks E.J., Hellerstein M.K. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000, 71:412-433.
4. Fried S.K., Rao S.P. Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 2003, 78:873S-880S.
5. Stanhope K.L., Havel P.J. Fructose consumption: recent results and their potential implications. Ann N Y Acad Sci 2010, 1190:15-24.
6. Nikpartow N., Danyliw A.D., Whiting S.J., Lim H., Vatanparast H. Fruit drink consumption is associated with overweight and obesity in Canadian women. Can J Public Health 2012, 103:178-182.
7. Malik V.S., Popkin B.M., Bray G.A., Despres J.P., Hu F.B. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121:1356-1364.
8. Brand-Miller J.C., Holt S.H., Pawlak D.B., McMillan J. Glycemic index and obesity. Am J Clin Nutr 2002, 76:281S-285S.
9. Schulze M.B., Hu F.B. Dietary approaches to prevent the metabolic syndrome: quality versus quantity of carbohydrates. Diabetes Care 2004, 27:613-614.
10. Stanhope K.L., Schwarz J.M., Keim N.L., Griffen S.C., Bremer A.A., Graham J.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009, 119:1322-1334.
11. Livesey G. Fructose ingestion: dose-dependent responses in health research. J Nutr 2009, 139:1246S-1252S.
12. Tappy L., Le K.A., Tran C., Paquot N. Fructose and metabolic diseases: new findings, new questions. Nutrition 2010, 26:1044-1049.
13. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
14. Tai M.M. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994, 17:152-154.
15. Aguila M.B., Pinheiro Ada R., Parente L.B., Mandarim-de-Lacerda C.A. Dietary effect of different high-fat diet on rat liver stereology. Liver Int 2003, 23:363-370.
16. Catta-Preta M., Mendonca L.S., Fraulob-Aquino J., Aguila M.B., Mandarim-de-Lacerda C.A. A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies. Virchows Arch 2011, 459:477-485.
17. Tschanz S.A., Burri P.H., Weibel E.R. A simple tool for stereological assessment of digital images: the STEPanizer. J Microsc 2011, 243:47-59.
18. Catta-Preta M., Martins M.A., Cunha Brunini T.M., Mendes-Ribeiro A.C., Mandarim-de-Lacerda C.A., Aguila M.B. Modulation of cytokines, resistin, and distribution of adipose tissue in C57BL/6 mice by different high-fat diets. Nutrition 2012, 28:212-219.
19. Santos C.F., Carneiro R.E., Mendonca L.S., Aguila M.B., Mandarim-de-Lacerda C.A. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet. Nutrition 2009, 25:818-827.
20. Lewis A.S., McCourt H.J., Ennis C.N., Bell P.M., Courtney C.H., McKinley M.C., et al. Comparison of 5% versus 15% sucrose intakes as part of a eucaloric diet in overweight and obese subjects: effects on insulin sensitivity, glucose metabolism, vascular compliance, body composition and lipid profile. A randomised controlled trial. Metabolism 2013, 62:694-702.
21. Swanson J.E., Laine D.C., Thomas W., Bantle J.P. Metabolic effects of dietary fructose in healthy subjects. Am J Clin Nutr 1992, 55:851-856.
22. Kuhlow D., Zarse K., Voigt A., Schulz T.J., Petzke K.J., Schomburg L., et al. Opposing effects of dietary sugar and saturated fat on cardiovascular risk factors and glucose metabolism in mitochondrially impaired mice. Eur J Nutr 2010, 49:417-427.
23. Shindo N., Fujisawa T., Sugimoto K., Nojima K., Oze-Fukai A., Yoshikawa Y., et al. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. J Hepatol 2010, 52:903-912.
24. Fraulob J.C., Ogg-Diamantino R., Santos C.F., Aguila M.B., Mandarim-de-Lacerda C.A. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010, 46:212-223.
25. Aguila M.B., Santos C.F., Pinheiro-Mulder A.R., Faria T.S., Mandarim-de-Lacerda C.A. Hepatic insulin resistance and nonalcoholic fatty liver disease. Insulin resistance: symptoms, causes and treatment 2010, 1-44. Nova Science Pu, Hauppauge, NY. J. Molière, L. Gauthier (Eds.).
26. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
27. Skurk T., Alberti-Huber C., Herder C., Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007, 92:1023-1033.
28. Akagiri S., Naito Y., Ichikawa H., Mizushima K., Takagi T., Handa O., et al. A mouse model of metabolic syndrome; increase in visceral adipose tissue precedes the development of fatty liver and insulin resistance in high-fat diet-fed male KK/Ta mice. J Clin Biochem Nutr 2008, 42:150-157.
29. Ahima R.S. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 2006, 14(Suppl. 5):242S-249S.
30. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998, 83:847-850.
31. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307:426-430.
32. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
33. Fumeron F., Aubert R., Siddiq A., Betoulle D., Pean F., Hadjadj S., et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004, 53:1150-1157.
34. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
35. Kshatriya S., Liu K., Salah A., Szombathy T., Freeman R.H., Reams G.P., et al. Obesity hypertension: the regulatory role of leptin. Int J Hypertens 2011, 2011:270624.
36. Tsochatzis E., Papatheodoridis G.V., Archimandritis A.J. The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol 2006, 101:2629-2640.
37. Koza R.A., Nikonova L., Hogan J., Rim J.S., Mendoza T., Faulk C., et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2006, 2:e81.
38. Qi Q., Wang J., Li H., Yu Z., Ye X., Hu F.B., et al. Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese. Eur J Endocrinol 2008, 159:585-593.
39. Wang P., Mariman E., Renes J., Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008, 216:3-13.
40. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
41. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., et al. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res 2005, 13:1311-1320.
42. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006, 116:115-124.
43. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006, 116:1494-1505.
44. Postic C., Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008, 118:829-838.
45. Ryu M.H., Sohn H.S., Heo Y.R., Moustaid-Moussa N., Cha Y.S. Differential regulation of hepatic gene expression by starvation versus refeeding following a high-sucrose or high-fat diet. Nutrition 2005, 21:543-552.
46. Miyazaki M., Dobrzyn A., Man W.C., Chu K., Sampath H., Kim H.J., et al. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J Biol Chem 2004, 279:25164-25171.
47. Dentin R., Girard J., Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 2005, 87:81-86.
48. Chen H., Dardik B., Qiu L., Ren X., Caplan S.L., Burkey B., et al. Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys. Endocrinology 2010, 151:3115-3124.
49. Reddy J.K., Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 2001, 21:193-230.
50. Magliano D.C., Bargut T.C., de Carvalho S.N., Aguila M.B., Mandarim-de-Lacerda C.A., Souza-Mello V. Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice. PLoS One 2013, 8:e64258.